FDA to Participate in Covid-19 Diagnostics Evidence Accelerator Project
Covid-19 Diagnostics Evidence Accelerator is a multi-stakeholder collaborative project to advance the development of diagnostics.
Read MoreSearch Results for: covid-19
Florida to Test All of the State’s Long-Term Care Residents and Staff for Covid-19
The initiative—in partnership with TestDirectly, Northwest Laboratory, and the Florida DOH—is expected to test 500,000 patient specimens.
Read More
Diagnostic Platform for Low Resource Settings Integrates Miniaturized Technologies with AI
The Gazelle Diagnostic platform is built around microchip electrophoresis technology that both identifies and quantifies many hemoglobin variants.
Read More
FDA Posts Template Updates for Developers of Molecular Diagnostic Tests for Covid-19
The updates address molecular diagnostic tests for pooling patient samples or for screening asymptomatic individuals not suspected of having covid-19.
Read More
Up to 45% of SARS-CoV-2 Infections May Be Asymptomatic, New Analysis Finds
Analysis of data from 16 groups of covid-19 patients highlights the need for expansive testing and contact tracing to mitigate the pandemic.
Read More